Fig. 1From: Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian populationOverall survival outcomes for patients with MCL. a In the overall cohort (n = 66), 68% of the patients were alive and 25.3% were progression-free at 5 years. Median OS and PFS were 105.7 months and 41.1 months, respectivelyBack to article page